They fail when review scope is based on systems rather than data sensitivity. If the same recertification process covers general customer records and PHI without separating approval criteria, the programme can appear complete while missing the stricter governance required for regulated health data.
Where access review programmes break down when data sensitivity is mixed
access review programmes fail when they treat all access as equivalent and use the same recertification criteria for general customer records and PHI. That approach can satisfy the calendar of reviews while missing the real question, which is whether the reviewer applied the stricter approval standard, evidence, and ownership expected for regulated health data.
The practical failure is not just incomplete coverage, but false confidence. A programme can report high completion rates even while PHI access is being approved on a lighter customer-data model, so the control looks mature on paper and weak in the place that matters most.
That is why access review design has to follow data sensitivity, not only the system or application name. Where the same application stores both customer data and PHI, the review should distinguish who can touch each data class, what justification is acceptable, and whether the approver has enough context to judge the risk.
Why one recertification process is not enough for PHI
General customer data and PHI often live in the same workflow, but they do not belong in the same approval logic. PHI usually carries stronger legal, contractual, and operational expectations around minimum necessary access, tighter review evidence, and clearer exception handling, so a single generic review form can quietly dilute those controls.
This is where teams commonly confuse completeness with adequacy. If a reviewer is asked only, “Should this user still have access?” they may answer based on role familiarity, not on whether the person needs access to regulated health data specifically.
Good programmes separate the entitlement review from the data classification. That means the same user may be approved for customer-service records but rejected, narrowed, or escalated for PHI access if the justification, job function, or exception evidence does not meet the stricter bar.
How to structure reviews so the sensitive data path stands on its own
The strongest pattern is to make PHI review criteria explicit and independently testable. Access reviews should show what data class is in scope, which entitlements expose that data, who owns the decision, and what evidence supports approval, reduction, or removal.
- Separate customer-record access from PHI access at the entitlement level where possible.
- Use different approval criteria for ordinary business access and regulated health data access.
- Require reviewers to see the data classification attached to each entitlement, not just the application name.
- Escalate exceptions for PHI rather than letting them pass through a generic business owner review.
- Track whether approvals are actioned, because a review that does not remove access is only a paper exercise.
For identity and access operating models, this is a governance problem as much as a permissions problem. NHIMG’s Access Reviews and Certification Guide is useful here because it frames reviews around removal of access, risk focus, and closed-loop remediation rather than simple attestation.
In the same vein, the IAM and IGA Basics resource is a good fit when you need to distinguish provisioning and recertification mechanics from the underlying authorization decision.
When mixed-sensitivity access is reviewed at scale, the review process should also be able to prove that PHI entitlements were considered separately from broader customer-data entitlements. Without that separation, the programme cannot demonstrate that it applied the correct governance standard to the higher-risk data class.
Risk and Threat Considerations
Mixed-sensitivity review programmes create a control gap when PHI access is hidden inside a broader customer-data population. The result is privileged or unnecessary access surviving because the review logic was designed for convenience rather than for the stricter consequences of regulated health information.
Failure mechanism: Reviewers approve access based on role familiarity, system ownership, or a generic business rationale, so PHI entitlements are never independently challenged and excessive access persists through the recertification cycle.
Impact: Organisations can expose regulated health data to inappropriate users, weaken audit defensibility, and miss the chance to remove overbroad access before it is used, shared, or abused.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 sets the technical controls, while ISO/IEC 27001:2022 and SOC 2 (AICPA) define the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | AC-6 — Least Privilege | Mixed-sensitivity reviews must reduce excess PHI access to least privilege. |
| IA-5 — Authenticator Management | Recertification often exposes stale credentials tied to continuing PHI access. | |
| AU-6 — Audit Record Review, Analysis, and Reporting | Review programmes need evidence that PHI access decisions were actually assessed. | |
| Recommendation — Review PHI entitlements separately and remove access that exceeds business need. Revalidate and rotate credentials tied to PHI access when reviews reveal unnecessary exposure. Use audit evidence to verify PHI access reviews were completed and acted on. | ||
| ISO/IEC 27001:2022 | A.5.15 — Access control | The question is about access control governance over differently sensitive data. |
| A.5.16 — Identity management | Access recertification depends on accurate ownership and identity scope. | |
| A.5.18 — Access rights | The issue is whether access rights are reviewed using the right sensitivity criteria. | |
| Recommendation — Define access rules that separate PHI decisions from ordinary customer-data access. Maintain ownership and identity records that distinguish PHI-authorised users from general users. Recertify access rights using data-class-specific approval criteria for PHI. | ||
| SOC 2 (AICPA) | CC6.1 — Logical and Physical Access Controls | The topic concerns whether access controls distinguish sensitive PHI from ordinary records. |
| CC6.3 — Logical Access Security | PHI review failures are logical access control failures when excess access persists. | |
| Recommendation — Apply separate access control approval logic for PHI and other customer data. Require PHI-specific review evidence before retaining access. | ||
Practitioner Guidance
What to verify: Confirm that PHI entitlements are tagged and reviewed separately from non-PHI customer records, with explicit approval criteria that require a health-data justification where applicable. If the reviewer cannot see the data class, the review is not trustworthy.
Common mistake: Do not rely on a single “access still needed” checkbox for every entitlement in the application. That shortcut is acceptable for low-sensitivity access, but it is too coarse for PHI because it hides the decision standard the reviewer actually used.
Decision rule: If an entitlement can reach PHI, treat it as a distinct review object, even when it sits inside the same application or role as ordinary customer-data access. The sharper the data sensitivity, the less acceptable it is to inherit approval from a broader review bucket.
Practitioner takeaway: A review programme is only strong when it can show that the most sensitive data path was evaluated on its own terms, not absorbed into a generic recertification workflow.